AbbVie (ABBV) stock price, revenue, and financials

AbbVie market cap is $126.3 b, and annual revenue was $33.27 b in FY 2019

$126.3 B

ABBV Mkt cap, 27-Feb-2020

$33.3 B

AbbVie Revenue FY, 2019
AbbVie Gross profit (FY, 2019)25.8 B
AbbVie Gross profit margin (FY, 2019), %77.6%
AbbVie Net income (FY, 2019)7.9 B
AbbVie EBIT (FY, 2019)13 B
AbbVie Cash, 31-Dec-201939.9 B
AbbVie EV153.2 B

AbbVie Revenue

AbbVie revenue was $33.27 b in FY, 2019

Embed Graph

AbbVie Revenue Breakdown

Embed Graph

AbbVie revenue breakdown by geographic segment: 34.3% from International and 65.7% from United States

AbbVie Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

25.6b28.2b32.8b33.3b

Revenue growth, %

12%10%16%

Cost of goods sold

5.8b7.0b7.7b7.4b

Gross profit

19.8b21.2b25.0b25.8b

Gross profit Margin, %

77%75%76%78%

R&D expense

4.4b5.0b10.3b6.4b

General and administrative expense

5.9b6.3b7.4b6.9b

Operating expense total

10.4b11.6b18.7b12.8b

EBIT

9.4b9.6b6.4b13.0b

EBIT margin, %

37%34%19%39%

Interest expense

965.0m1.0b1.1b

Pre tax profit

7.9b7.7b5.2b8.4b

Income tax expense

1.9b2.4b(490.0m)544.0m

Net Income

6.0b5.3b5.7b7.9b

AbbVie Balance Sheet

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

5.1b9.3b7.3b39.9b

Accounts Receivable

4.8b5.1b5.4b5.4b

Prepaid Expenses

3.6b4.7b1.9b2.4b

Inventories

1.4b1.6b1.6b1.8b

Current Assets

16.2b21.2b16.9b49.5b

PP&E

2.6b2.8b2.9b3.0b

Goodwill

15.4b15.8b15.7b15.6b

Total Assets

66.1b70.8b59.4b89.1b

Accounts Payable

9.4b10.2b1.5b1.5b

Short-term debt

402.0m6.4b5.3b3.8b

Current Liabilities

9.8b16.6b17.2b15.6b

Long-term debt

36.4b31.0b35.0b63.0b

Total Debt

36.8b37.4b40.3b66.7b

Common Stock

18.0m18.0m18.0m18.0m

Additional Paid-in Capital

13.7b14.3b14.8b15.2b

Retained Earnings

4.4b5.5b3.4b4.7b

Total Equity

4.6b5.1b(8.4b)(8.2b)

EPS

3.63.33.7

Debt to Equity Ratio

7.9 x7.3 x-4.8 x

Debt to Assets Ratio

0.6 x0.5 x0.7 x

Financial Leverage

14.3 x13.9 x-7 x-10.9 x

AbbVie Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

6.0b5.3b5.7b7.9b

Depreciation and Amortization

1.2b1.5b1.8b464.0m

Accounts Receivable

(71.0m)(391.0m)(591.0m)(74.0m)

Inventories

(38.0m)93.0m(226.0m)(231.0m)

Accounts Payable

(1.2b)425.0m190.0m(1.1b)

Cash From Operating Activities

7.0b10.0b13.4b13.3b

Purchases of PP&E

(529.0m)(638.0m)(552.0m)

Cash From Investing Activities

(6.1b)(274.0m)(1.0b)596.0m

Short-term Borrowings

(29.0m)22.0m299.0m

Long-term Borrowings

(6.0b)(25.0m)(6.0b)(1.5b)

Dividends Paid

(3.7b)(4.1b)(5.6b)(6.4b)

Cash From Financing Activities

(3.9b)(5.5b)(14.4b)18.7b

Net Change in Cash

(3.3b)4.2b(2.0b)32.6b

Interest Paid

986.0m1.1b1.2b1.8b

Income Taxes Paid

3.6b1.7b1.4b

AbbVie Ratios

USDY, 2019

EV/EBIT

11.8 x

EV/CFO

11.5 x

Revenue/Employee

1.1m

Financial Leverage

-10.9 x

AbbVie Operating Metrics

AbbVie's Patients was reported to be 30 m in Jan, 2020.
Jan, 2020

Manufacturing Facilities

22

Patients

30 m

Programs

292

AbbVie Employee Rating

3.71335 votes
Culture & Values
3.6
Work/Life Balance
3.5
Senior Management
3.2
Salary & Benefits
4.0
Career Opportunities
3.3
Source